HEARTLAB’S CARDIONOW EXPANDS INSTALLATION BASE TO INCLUDE WORLD’S LEADING INTRAVASCULAR ULTRASOUND CORE LABORATORY
Stanford’s Cardiovascular Core Analysis Laboratory deploys Heartlab’s CardioNow internet-based image management solution for cardiovascular clinical trials.
- Press release
- WESTERLY, RI
- July 07, 2004 11:45
Heartlab, the world’s leading designer and supplier of digital image and information networks for cardiology
Heartlab, the world's leading designer and supplier of digital image and information networks for cardiology, today announced that the Stanford Center for Research in Cardiovascular Interventions has installed Heartlab's CardioNow DICOM telecardiology and image management solution for cardiovascular device and drug studies at its Stanford Cardiovascular Core Analysis Laboratory.
The Stanford Cardiovascular Core Analysis Laboratory (CCAL) will utilize CardioNow to streamline and expedite the receipt, tracking, archiving, and analysis of complex cardiac images from hospital investigator sites around the world. This installation represents the fourth cardiovascular core lab to endorse Heartlab's CardioNow web-based solution for clinical trial image management. Other leading cardiovascular core labs already utilizing CardioNow include the Cardiovascular Research Foundation (New York), Brigham & Womens Angiographic Core Lab (Boston) and The University of Florida Shands Cardiovascular Imaging Core Laboratories (Jacksonville).
Heartlab's web-based CardioNow technology enables hospital investigator sites to easily share DICOM studies required by certain cardiovascular drug and device clinical trails. Within minutes of initial patient enrollment, study images can be transferred electronically from investigator sites to angiographic and ultrasound core labs anywhere in the world for analysis. Additionally, these studies can be made available online for simultaneous review by other stakeholders such as clinical event committee members, safety monitoring board members and trial sponsors.
"Clinical trials brought online with CardioNow provide trial sponsors, investigator sites and core labs with tremendous benefits compared to the traditional information management methods. Heartlab's technology eliminates the physical mailing, tracking, archiving and analyzing of angiograms, echocardiograms or intravascular ultrasound studies. It can shave weeks or months off the duration of a clinical trial and helps decrease time to market for new drugs and devices that require clinical trails with imaging endpoints," commented Heartlab CEO Robert Petrocelli. "We are extremely excited that the world's leading intravascular ultrasound core laboratory will be utilizing the benefits offered by our CardioNow technology."
Additional information on Heartlab's CardioNow image management solution for clinical trials can be obtained at http://www.heartlab.com/cardionow.htm.
About Heartlab
Heartlab is the world's leading designer and supplier of digital image and information networks for Cardiology. Named one of America's fastest-growing private companies for the fourth year in a row by Inc. magazine, Heartlab develops application software and integrates systems using industry-standard computer hardware, including Heartlab's own StoreSafe® DVD-R archiving and Oracle's database technology. Heartlab's Encompass™ network gives cardiologists rapid access to imaging exam and report information, enables cardiology centers to operate more efficiently, and provides robust protection for critical patient data. Heartlab's Encompass networks are installed in more than 225 of the nation's leading heart centers. The company's CardioNow image management solution for clinical trials has been utilized by leading cardiovascular core labs and cardiovascular device and drug companies to expedite the sharing, tracking and analysis of complex cardiac images for over 25 multi-center clinical trails including drug-eluting stent, bare metal stent, as well as distal protection device studies. For more information, visit www.Heartlab.com.
About Stanford Center for Research in Cardiovascular Interventions
Founded in 1994 by Drs. Fitzgerald and Yock, the Stanford Center for Research in Cardiovascular Interventions serves as a resource for both scientific and technologic growth in the field of cardiovascular medicine. With expertise in the field of quantitative coronary ultrasound (QCU) analysis and quantitative coronary angiography (QCA), the center's state-of-the-art core imaging laboratory, known as the Cardiovascular Core Analysis Laboratory (CCAL), has been actively involved with a number of large multi-center trials, including the NIH sponsored trials, BARI and SCRIP. The QCU laboratory is the world's leading IVUS core lab, with participation in over 45 U.S. and international multi-center trials including ABACAS, DESIRE, SIRIUS, TAXUS, ENDEAVOR and FUTURE. The center includes over 13 staff physicians including Dr. Yasuhiro Honda who serves as the associate director, three research and data coordinators, one bioinformatics specialist, and two administrative assistants. For more information visit http://ccal.stanford.edu/.